PATENT CLAIM ANALYSIS

Application Number: 15981423
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["424", "400000"]

Abstract:
The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed.

Claim (Index 13):
The method of  claim 11 , wherein the hepato-renal syndrome (HRS) is HRS II.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 93.0
- Lexical Diversity: 1.53968
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13233824', '13281129', '14188139', '15044949', '11547568']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7760687705798579
- 35 USC 102 Novelty (BERT): 0.5541804207528318
- Combined Prediction Score: 0.7538799355971554
- Mean Citation Score: 316.66818
- Max Citation Score: 365.3364
- Similarity Product: 179.3855280141592

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test